Understand the bias, discover the truth in your news. Get Started
News News
Bias Charts - New
Services
Pricing
Bias Meter
Tools
Regeneron Pharmaceuticals Follow
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Nucleic acid sequence
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
NY Times
May 19, 2025

-12% Somewhat Left

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Biobank
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Business Insider
May 19, 2025

-18% Somewhat Left

Rochester students qualify for Regeneron International Science and Engineering Fair
Century High School (Bismarck, North Dakota)
Rochester students qualify for Regeneron International Science and Engineering Fair

Mar 11, 2025

-8% Center

Regeneron Pharmaceuticals Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
Whitehead Institute
Regeneron Pharmaceuticals Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
Green Stock News
Jul 31, 2024

-16% Somewhat Left

default thumbnail
Whitehead Institute
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
Market Screener
Jul 31, 2024

-16% Somewhat Left

Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
Non-small-cell lung carcinoma
Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
Yahoo News
Sep 11, 2022

0% Center

FDA Suddenly Pulls Monoclonal Antibody Treatment EUAs: 'They are Not a Substitute for Vaccination'
Monoclonal antibody
FDA Suddenly Pulls Monoclonal Antibody Treatment EUAs: 'They are Not a Substitute for Vaccination'
Nwo Report
Jan 26, 2022

56% Medium Right

DeSantis furious after FDA pulls authorization of antibody drugs: 'Sudden and reckless' -- Sott.net
Antibody
DeSantis furious after FDA pulls authorization of antibody drugs: 'Sudden and reckless' -- Sott.net
Signs Of The Times
Jan 26, 2022

98% Very Right

FDA Uses
SARS-CoV-2 Omicron variant
FDA Uses "Omicron" as Excuse to End Emergency Use Authorization for Monoclonal Antibody Treatments
Le·gal In·sur·rec·tion
Jan 26, 2022

56% Medium Right

The Morning Dispatch: Much Ado About Monoclonal Antibodies
Regeneron Pharmaceuticals
The Morning Dispatch: Much Ado About Monoclonal Antibodies
The Morning Dispatch
Jan 26, 2022

38% Somewhat Right

DeSantis slams Team Biden for revoking monoclonal antibody treatments
Monoclonal antibody
DeSantis slams Team Biden for revoking monoclonal antibody treatments
World Tribune: Window on the Real World
Jan 26, 2022

98% Very Right

New drug for COVID treatment remains scarce in Las Vegas
Monoclonal antibody
New drug for COVID treatment remains scarce in Las Vegas
Las Vegas Review-Journal
Jan 26, 2022

-16% Somewhat Left

New drug for treatment of COVID remains scarce in Las Vegas
Merta City
New drug for treatment of COVID remains scarce in Las Vegas
Las Vegas Review-Journal
Jan 26, 2022

-16% Somewhat Left

Gov. DeSantis: State Needs Additional 30,000 To 40,000 Monoclonal Antibody Treatment Doses
Regeneron Pharmaceuticals
Gov. DeSantis: State Needs Additional 30,000 To 40,000 Monoclonal Antibody Treatment Doses
CBS4 Miami
Jan 04, 2022

-44% Medium Left

DeSantis Demands Feds Allow Florida to Buy $1 Billion in COVID Treatment Top Donor Has Invested In
Regeneron Pharmaceuticals
DeSantis Demands Feds Allow Florida to Buy $1 Billion in COVID Treatment Top Donor Has Invested In
The New Civil Rights Movement
Jan 04, 2022

-22% Somewhat Left

View More